New Therapeutic Uses Funding Information
NIH launched the New Therapeutic Uses pilot program in May 2012. By pairing researchers with a selection of industry-provided molecular compounds, the goal of this innovative program is to test ideas for new therapeutic uses, ultimately identifying promising new treatments for patients.
In June 2013, NIH awarded $12.7 million to fund two-year and three-year cooperative agreements for nine projects in areas that include alcoholism, a type of progressive lung disease and cigarette smoking cessation. The NIH Common Fund is supporting the pilot phase of this NCATS-led program. If specific milestones are met, funded researchers will conduct pre-clinical validation, clinical feasibility studies, or proof-of-concept clinical trials to test whether selected compounds are effective against a previously unexplored disease target.
These now-expired funding announcements include details on the application process, eligibility and associated timelines:
NOT-TR-12-010: Technical Assistance Webinar for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules Limited Competition RFA-TR-12-004 (UH2/UH3) and RFA-TR-12-005 (UH3)
- Discovering New Therapeutic Uses for Existing Molecules
- 2013 Project Awards
- FAQ About New Therapeutic Uses
- New Therapeutic Uses Contacts
- Request for Program Feedback
- NIH Grant Information
- Apply for NIH Grants
- NIH Guide for Funding Opportunities
- NIH Grant FAQs
- Therapeutics for Rare and Neglected Diseases
- Bridging Interventional Development Gaps
Join NCATS Listservs
Frequently Asked Questions
- About New Therapeutic Uses
- About the UH2/UH3 and UH3 Limited Competition Application (Expired 12/18/12)
- About the X02 Pre-Application PAR-12-203 (Expired 8/15/12)
Technical Assistance Webinar
NCATS held a New Therapeutic Uses technical assistance webinar on Monday, June 25, 2012. Download the slides from this event.